Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

NuvaRing

CompanyOrganon LLC (DUNS: 117494753)

Effective Date

January 9, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Etonogestrel(0.12 mg in 1 d)

Ethinylestradiol(0.015 mg in 1 d)

Products (1)

NuvaRing

NDC Product Code

78206-146

Application Number

NDA021187

Marketing Category

NDA (C73594)

Route of Administration

VAGINAL

Effective Date

January 9, 2023

Ingredients

EtonogestrelActive

Code: 304GTH6RNHClass: ACTIBQuantity: 0.12 mg in 1 d

EthinylestradiolActive

Code: 423D2T571UClass: ACTIBQuantity: 0.015 mg in 1 d

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE)Inactive

Code: 8ILA5X28VSClass: IACT

ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE)Inactive

Code: 4OKC630HS6Class: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy